Molecular Oncology, EarlyView.In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source
Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success. [PDF]
J Headache PainPellesi L, Edvinsson L.
europepmc +1 more source
Retracted: Elevated Substance P Is a Risk Factor for Postoperative Delirium in Patients with Hip Fracture. [PDF]
Biomed Res Int, 2023 International BR.
europepmc +1 more source
A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer
Molecular Oncology, EarlyView.Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla +15 more
wiley +1 more source
Substance P release from rat dura mater is inversely correlated with CGRP release- experiments using glycerol trinitrate and anti-CGRP antibodies. [PDF]
J Headache PainDux M, Messlinger K.
europepmc +1 more source
Substance P promotes epidural fibrosis via induction of type 2 macrophages. [PDF]
Neural Regen Res, 2023 Hua F +7 more
europepmc +1 more source
A transient release of potassium mediated by the action of substance P on rat parotid slices.
, 1978 Zeev Friedman, Zvi Selinger
openalex +1 more source
THE EFFECTS OF CHRONIC SECTION OF DORSAL ROOTS ON THE RESPONSIVENESS OF MOTONEURONES TO 5‐HYDROXYTRYPTAMINE AND A SUBSTANCE P ANALOGUE [PDF]
, 1981 M.H.T. Roberts, D.M. Wright
openalex +1 more source
Molecular Oncology, EarlyView.This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source